Source: Annual Congress 2004 - Systemic and metabolic effects from OSA
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. R. Bonsignore, A. Salvaggio, M. Gioia, A. Bonanno, M. Profita, L. Riccobono, M. R. Melis, E. Cillari, G. Insalaco, O. Marrone, V. Bellia, G. Bonsignore (Palermo, Italy). Erythrocyte production in obstructive sleep apnea. Eur Respir J 2004; 24: Suppl. 48, 4236

Member's Comments

No comment yet.

Related content which might interest you: Erythrocyte glycolysis in severe obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 354s Year: 2005 Cortisol metabolism in obstructive sleep apnea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 215s Year: 2002 Catecholamine secretion in obstructive sleep apnoea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005 Leptin in obstructive sleep apnea Source: Eur Respir J 2001; 18: Suppl. 33, 333s Year: 2001 Oxygen for the treatment of obstructive sleep apnoea hypopnoea syndrome Source: Breathe, 15 (3) e104; 10.1183/20734735.0206-2019 Year: 2019 Increased rates of obstructive sleep apnea (OSA) in COVID-19-patients Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19 Year: 2021 Change in PLMS after treatment of obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 593s Year: 2007 Prevalence of complex sleep apnea among German patients with obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Pathophysiological consequences of obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 The velumount device for obstructive sleep apnoea Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Awakening headaches are associated with obstructive sleep apnea Source: Eur Respir J 2002; 20: Suppl. 38, 452s Year: 2002 Hypertension and obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007 Endothelial function in obstructive sleep apnea syndrome Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011 Peculiarities of nocturnal oxygen saturation in obstructive sleep apnoea Source: Eur Respir J 2004; 24: Suppl. 48, 119s Year: 2004 Albuminuria in children with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011 Effect of obstructive sleep apnea on asthma control Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020 Nocturnal release of leukocyte-derived microparticles in males with obstructive sleep apnoea Source: Eur Respir J 2011; 37: 1293-1295 Year: 2011 Predictors of hypercapnia in obstructive sleep apnoea (OSA) Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control Year: 2010 Association between obstructive sleep apnea hypopnea and metabolic syndromes Source: Eur Respir J 2004; 24: Suppl. 48, 692s Year: 2004